Comparison of the efficacy and safety of T2750 and Vismed® in the treatment of moderate to severe Dry Eye Syndrome
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
93
Unnamed facility
Paris, France
Global Ocular Staining (With Oxford Scale - Ranges :0-15)
Change from baseline in the worse eye on Day 35 (decrease of Oxford score = better outcome)
Time frame: Baseline and 35 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.